Researchers from McMaster University and the Firestone Institute for Respiratory Health at St. Joseph’s Healthcare Hamilton, together with colleagues at other partnering institutions, have developed a new method to treat severe asthma.
In a study of over 200 participants with severe asthma, the new treatment was shown to have improved asthma symptoms and lung function, while reducing the need for corticosteroids by up to 70%.
According to Statistics Canada, eight per cent of Canadians aged 12 or older – approximately 2.4 million people – have been diagnosed with asthma. Of that, approximately 25% are considered to be severe cases of asthma.
Current treatments for severe asthma often include high doses of corticosteroids, such as prednisone, to control exacerbations. Reducing the need for corticosteroids with alternative treatments is preferable, since these medications are associated with serious side effects from prolonged use – including multi-organ toxicities and immunosuppression.
Parameswaran Nair, professor of medicine at McMaster and staff respirologist at St. Joseph’s Healthcare Hamilton, along with a team of researchers found that an antibody called dupilumab is effective in treating severe asthma in place of high doses of prednisone.
The results were published in the New England Journal of Medicine, one of the world’s most influential medical publications.
Researchers sought participants who had been using oral corticosteroids (prednisone) to treat severe asthma for at least six months prior to the study. In addition to their standard regimen of corticosteroids, patients received either dupilumab or a placebo during the 24 week trial. The corticosteroid dose was gradually reduced during weeks four to 20, and maintained at a low level for the final four weeks.
“The ability of dupilumab to increase lung function as markedly as it did in this study, even in the face of [corticosteroid] withdrawal, indicates that it appears to be inhibiting key drivers of lung inflammation,” the researchers noted.
Dupilumab works to treat asthma by blocking two specific proteins (called interleukin-4 and interleukin-13) that are associated with inflammation of the airways.
This technique was based on Nair’s previous research, (published in the New England Journal of Medicine in 2009 and in 2017). Those studies found that blocking another protein, interleukin-5, allowed patients with high eosinophil levels in their blood and airways to reduce their corticosteroid dose. Eosinophils are a type of white blood cell involved with the production of interleukins. High eosinophil levels are directly linked to an increased risk of severe asthma.
Unlike the previous studies, dupilumab was shown to be effective regardless of patients’ eosinophil levels. Despite the reduced prednisone dose, patients in this study not only experienced a decrease in asthma exacerbations, but their lung function also improved significantly.
“Ultimately, our goal is to find new treatment pathways that allow us to circumvent the use of corticosteroids,” said Nair.
“Since dupilumab showed a significant improvement on asthma control regardless of eosinophil levels, we may be able to use this treatment for a wider range of patients than we previously thought possible. This might be due to the broad effects on inflammation in asthma of the two proteins that we were able to block with dupilumab. The treatment was not associated with any serious side effects.”
The Latest on: Asthma
via Google News
The Latest on: Asthma
Meta-Analysis: Significant Association Between ADHD and Asthma
on August 16, 2018 at 3:02 pm
Awareness of this strong association may have a significant clinical and public health impact as ADHD specialists can refer patients with early forms of asthma, and asthma specialists can refer patien... […]
PCCI Combines Predictive Modeling, Patient Engagement to Address Pediatric Asthma
on August 16, 2018 at 2:25 pm
Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of ... […]
Links seen between asthma and ADHD
on August 16, 2018 at 2:07 pm
(Reuters Health) - There may be a strong connection between asthma and attention deficit hyperactivity disorder (ADHD) that makes people with one condition more likely to develop the other one, a rece... […]
Air pollution: London mayor backs new inquest into girl's asthma death
on August 16, 2018 at 4:38 am
Ella Kissi-Debrah died following an asthma attack on 15 February 2013. An expert in respiratory medicine has said there was a “real prospect that without illegal levels of air pollution Ella would not ... […]
Labetalol Use Up for Patients With Preeclampsia and Asthma
on August 15, 2018 at 12:55 pm
HealthDay News — Higher rates of β-blocker use are seen among women with preeclampsia and asthma, according to a study published in the July issue of Obstetrics & Gynecology. Whitney A. Booker, MD, fr... […]
Biologic Therapy Selection for Severe Asthma: Factors to Consider
on August 15, 2018 at 7:24 am
Asthma endotype, clinical biomarkers, and patient-specific factors should all be considered when selecting a biologic treatment for patients with severe asthma, according to a new review published in ... […]
State grant to help Springfield residents deal with asthma
on August 14, 2018 at 7:59 pm
SPRINGFIELD, Mass. (WWLP) - A program in Springfield has received new funding to help fight asthma in the city. The Asthma and Allergy Foundation of America recently named Springfield America's most c... […]
Baystate Health gets $750K grant to expand asthma program
on August 14, 2018 at 10:29 am
SPRINGFIELD - A Baystate Health partnership formed to served MassHealth enrollees through the model of an Accountable Care Organization has been awarded a $750,000 state grant to expand in-home asthma ... […]
Combination ICS/LABA inhalers safe to use for asthma, study confirms
on August 14, 2018 at 7:56 am
Combination inhalers containing a long-acting beta-2 agonist (LABA) and an inhaled corticosteroid (ICS) can be safely used to treat asthma without increased safety concerns, a team of international re... […]
via Bing News